US Stock MarketDetailed Quotes

NVNBW ENVVENO MED CORP C/WTS 11/02/2026 (TO PUR COM)

Watchlist
  • 1.000
  • 0.0000.00%
15min DelayTrading Jul 22 16:00 ET
0Market Cap0.00P/E (TTM)

ENVVENO MED CORP C/WTS 11/02/2026 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-19.04%5.5M
1.23%25.24M
-2.82%6.28M
-13.04%5.35M
-2.46%6.81M
27.40%6.8M
47.59%24.93M
-28.17%6.46M
127.23%6.15M
192.79%6.99M
Selling and administrative expenses
-23.45%2.45M
-22.39%11.66M
-9.99%3.3M
-30.28%2.55M
-33.55%2.6M
-15.36%3.2M
34.51%15.02M
-49.20%3.66M
146.90%3.66M
201.93%3.91M
Research and development costs
-15.10%3.05M
37.01%13.58M
6.58%2.98M
12.28%2.8M
37.13%4.21M
131.64%3.6M
73.08%9.91M
56.96%2.8M
103.43%2.49M
181.93%3.07M
Operating profit
19.04%-5.5M
-1.23%-25.24M
2.82%-6.28M
13.04%-5.35M
2.46%-6.81M
-27.40%-6.8M
-47.59%-24.93M
28.17%-6.46M
-127.23%-6.15M
-192.79%-6.99M
Net non-operating interest income expense
31.11%59K
11.80%180K
18.18%52K
-41.33%44K
5.41%39K
800.00%45K
747.37%161K
780.00%44K
1,400.00%75K
428.57%37K
Non-operating interest income
31.11%59K
11.80%180K
18.18%52K
-41.33%44K
5.41%39K
800.00%45K
747.37%161K
780.00%44K
1,400.00%75K
--37K
Other net income (expense)
25.56%452K
1,411.76%1.54M
144.49%577K
1,547.62%304K
366.37%301K
360K
-70.52%102K
236K
-106.71%-21K
-11,400.00%-113K
Gain on sale of security
25.56%452K
1,411.76%1.54M
144.49%577K
1,547.62%304K
366.37%301K
--360K
--102K
--236K
---21K
---113K
Income before tax
21.90%-4.99M
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
-196.97%-7.06M
Income tax
Net income
21.90%-4.99M
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
-196.97%-7.06M
Net income continuous Operations
21.90%-4.99M
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
-196.97%-7.06M
Minority interest income
Net income attributable to the parent company
21.90%-4.99M
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
-196.97%-7.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
21.90%-4.99M
4.67%-23.52M
8.59%-5.65M
17.98%-5M
8.33%-6.47M
-19.92%-6.39M
-49.26%-24.67M
31.24%-6.18M
-155.21%-6.1M
-196.97%-7.06M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -19.04%5.5M1.23%25.24M-2.82%6.28M-13.04%5.35M-2.46%6.81M27.40%6.8M47.59%24.93M-28.17%6.46M127.23%6.15M192.79%6.99M
Selling and administrative expenses -23.45%2.45M-22.39%11.66M-9.99%3.3M-30.28%2.55M-33.55%2.6M-15.36%3.2M34.51%15.02M-49.20%3.66M146.90%3.66M201.93%3.91M
Research and development costs -15.10%3.05M37.01%13.58M6.58%2.98M12.28%2.8M37.13%4.21M131.64%3.6M73.08%9.91M56.96%2.8M103.43%2.49M181.93%3.07M
Operating profit 19.04%-5.5M-1.23%-25.24M2.82%-6.28M13.04%-5.35M2.46%-6.81M-27.40%-6.8M-47.59%-24.93M28.17%-6.46M-127.23%-6.15M-192.79%-6.99M
Net non-operating interest income expense 31.11%59K11.80%180K18.18%52K-41.33%44K5.41%39K800.00%45K747.37%161K780.00%44K1,400.00%75K428.57%37K
Non-operating interest income 31.11%59K11.80%180K18.18%52K-41.33%44K5.41%39K800.00%45K747.37%161K780.00%44K1,400.00%75K--37K
Other net income (expense) 25.56%452K1,411.76%1.54M144.49%577K1,547.62%304K366.37%301K360K-70.52%102K236K-106.71%-21K-11,400.00%-113K
Gain on sale of security 25.56%452K1,411.76%1.54M144.49%577K1,547.62%304K366.37%301K--360K--102K--236K---21K---113K
Income before tax 21.90%-4.99M4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M-196.97%-7.06M
Income tax
Net income 21.90%-4.99M4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M-196.97%-7.06M
Net income continuous Operations 21.90%-4.99M4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M-196.97%-7.06M
Minority interest income
Net income attributable to the parent company 21.90%-4.99M4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M-196.97%-7.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 21.90%-4.99M4.67%-23.52M8.59%-5.65M17.98%-5M8.33%-6.47M-19.92%-6.39M-49.26%-24.67M31.24%-6.18M-155.21%-6.1M-196.97%-7.06M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg